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Abstract 
Cationic defence peptides show high therapeutic potential as antimicrobial and 
anticancer agents. Some of these peptides carry a C-terminal amide moiety which 
appears to be required for antimicrobial activity. However, whether this is a general 
requirement and whether C-terminal amidtion is required for the anticancer activity of 
defence peptides is unclear. In reponse, we analyse the toxicity of a series of C-
terminally amidated defence peptides and their non-amidated isoforms to normal 
fibrolast cells, a variety of tumour cells and bacterial cells. The toxicities of these 
peptides to microbial and cancer cells were generally < 200 μM and could either be 
unaffected by C-terminal amidation or show up to ten-fold decreases or increases. 
However, these peptides all showed toxcity to normal fibrolast cells with levels 
(generally < 150 μM) that were comparable to those of their antimicrobial and 
anticancer activities. In combination, these results clearly show that the C-terminal 
amidation of defence peptides has a variable effect on their antimicrobial and 
anticancer efficacy but no effect on their selectivity for these cell types. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
The increasing occurrences of resistance to antimicrobial and anticancer 
agents are two major problems facing medical research and defence peptides are 
attractive propositions for the solution of both problems. These peptides have a major 
advantage over conventional antibiotics and anticancer drugs in that currently 
microbes and tumours show little evidence of resistance to their toxic action, which 
involves relatively non-specific interactions with target cell membranes (REF). 
Nonetheless, a full understanding of factors influencing the antimicrobial and 
anticancer activities of defence peptides is still lacking, which hampers development 
of their full therapeutic potential (Hoskin et al., 2008; Amaral et al., 2007).  
It is generally accepted that the ability of defence peptides to kill microbes and 
cancer cells primarily depends upon their positive charge, which enables electrostatic 
binding to anionic components of the target cell membrane, and their structural 
amphiphilicity, which facilitates bilayer penetration and disruption with cell death 
resulting. It is also well established that the positive charge carried by defence 
peptides mainly derives from the presence of lysine and arginine residues within their 
sequences (Dennison et al., 2005). However, the positive charge of some defence 
peptides also includes a contribution from a C-terminal amide moiety and there is 
evidence to suggest that the presence of this amide group enhances the antimicrobial 
activity of some defence peptides. Examples where this has been demonstrated 
include: the α-helical amphibian peptide, PGLa (Strandberg et al., 2007), the β-sheet 
human α-defensin, HNP2 (Xie et al., 2005), and the turn / turn porcine peptide, 
tritrpticin (Schibli et al., 2006).  
Over the last decade, it has become clear that the antimicrobial and anticancer 
actions of defence peptides show similarities. In particular, the ability of defence 
peptides kill cancer cells also involves electrostatic interactions between these 
cationic peptides and anionic components of the cancer cell membrane (Dennison et 
al., 2005). Based on this observation, it has recently been suggested that C-terminal 
amidification may enhance the anticancer activity of defence peptides (Apponyi et al., 
2004) although little research into this possibility appers to have been undertaken. 
Here, we have investigated these suggestions by assembling a database of C-
terminally amidated peptides along with their non-amidated isoforms and analysed 
their toxicity to a variety of eukaryotic and prokaryotic cells.  
Methods 
Database assembly and cell line toxicity analysis 
The sequences of a series of C-terminally amidated (AM) peptides along with 
their non-C-terminally amidated (AC) isoforms (Table 1) were extracted from a 
database of naturally occurring and synthetic defence peptides (Owen, 2005). Toxicity 
data for these AC / AM isoforms against WI38, a normal fibroblast cell line of the 
lung diploid cells, and a variety tumour cell lines were extracted as the half lethal dose 
(LD50). These tumour cell lines included MCF7 - a breast adenocarcinoma tumour cell 
line, SW480 - a colon adenocarcinoma tumour cell line, BMKC - a cloned melanoma 
cell line, H1299 - a lung large cell carcinoma tumour cell line, HeLaS3 - a cervical 
epithelial carcinoma cell line and PC3 – a prostate adenocarcinoma tumour cell line. 
Also extracted was toxicity data for these AC / AM isoforms (Table 1) against 
Escherichia coli (Accession number ATCC 25922), Pseudomonas aeruginosa 
(Accession number ATCC 27853) and Staphylococcus aureus (Accession number 
ATCC 25923) as the minimum inhibitory concentration (MIC). These various toxicity 
data were then graphically represented and compared to detect putative relationships 
between the toxicity levels of these peptides and their possession of C-terminal 
amidation.  
 
Name Sequence 
Hectate AC FALALKALKKALKKLKKALKKAL-COOH 
Hectate AM FALALKALKKALKKLKKALKKAL-NH2 
SB-37 AC MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG-COOH 
SB-37 AC MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG-NH2 
Shiva 10 AC FAKKLAKKLKKLAKKLAKLALAL-COOH 
Shiva 10 AM FAKKLAKKLKKLAKKLAKLALAL-NH2 
FLAK06 AC FALALKALKKLKKALKKAL-COOH 
FLAK06 AM FALALKALKKLKKALKKAL-NH2 
FLAK 26 AC FAKKLAKLAKKLAKLAL-COOH 
FLAK 26 AM FAKKLAKLAKKLAKLAL-NH2 
Shiva 10(1-18) AC FAKKLAKKLKKLAKKLAK-COOH 
Shiva 10 (1-18) AM FAKKLAKKLKKLAKKLAK-NH2 
CA(1-7)Shiva10(1-16)  AC KWKLFKKKTKLFKKFAKKLAKKL-COOH 
CA(1-7)Shiva10(1-16) AM KWKLFKKKTKLFKKFAKKLAKKL-NH2 
Modelin-5 AC KLAKKLAKLAKLAKAL-COOH 
Modelin-5 AM KLAKKLAKLAKLAKAL-NH2 
Hecate ACV AC VALALKALKKALKKLKKALKKAL-COOH 
Hecate AMV AM VALALKALKKALKKLKKALKKAL-NH2 
Table 1: Shown above are the sequences of C-terminally amidated peptides (AM) and 
their non-C-terminally amidated (AC) isoforms, which were extracted from the 
database of Owen (2005). 
 
Results and Discussion 
Factors influencing the antimicrobial and anticancer activities of defence 
peptides are poorly understood. To gain further insight into these factors, the present 
study investigates the possibility that the C-terminal amide group carried by some 
defence peptides may enhance their antimicrobial and anticancer action.  
To date, most studies on defence peptides have focused on their antimicrobial 
activity. These studies showed that C-terminal amidation is the most common post-
translational modification of defence peptides, which clearly suggested biological 
relevance, and led a number of recent studies to show that possession of this C-
terminal moiety enhanced the antimicrobial activity of these peptides (Strandberg et 
al., 2007; Xie et al., 2005; Schibli et al., 2006). To test the generality of this effect, the 
present study compared the toxicity of a series of C-terminally amidated (AM) 
peptides to prokaryotic cells with that of their non-C-terminally amidated (AC) 
isoforms (Table 1). In general, the AM and AC isoforms in Table 1 are strongly 
antibacterial with levels of toxicity that lie in the range 5-150 μM (Figure 1). 
Consistent with the results of recent studies (Strandberg et al., 2007; Xie et al., 2005; 
Schibli et al., 2006), analysis of these toxicity data found that the AM isoform of 
FLAK 06 showed activity against Escherichia coli and Aeruginosa pseudomonas, 
which was up to five-fold higher than that of its AC counterpart. However, in contrast, 
the AC isoforms of Shiva 10 and Modelin 5 were circa fifteen-fold more effective 
against these organisms than the corresponding AM peptides. In all cases, the AM and 
AC isoforms of the remaining peptides studied showed toxicity to these Gram-
negative bacteria but no correlation between isoform type and toxicity levels was 
observed with C-terminal amidation being seen to both decease and increase efficacy. 
The toxicity of the peptides in Table 1 against Gram-positive bacteria was analysed 
and it was found that the potency of Shiva 10 and FLAK 26 AM isoforms to 
Staphylococcus aureus was up to eight-fold higher than their AC counterparts. 
However, the AC isoforms of SB-37 and FLAK 06 showed potency to this organism, 
which was two-fold higher than that of the corresponding AM peptides. The AM and 
AC isoforms of the remaining peptides all showed toxicity to S. aureus but for each 
peptide, no difference in potency between isoform types was observed. These data 
clearly show that the toxicity of defence peptides to microbial cells can be unaffected, 
increased or decreased by the presence of a C-terminal amide moiety, indicating that 
this structural modification has a variable effect on their antimicrobial efficacy. The 
effect of C-terminal amidation on the microbial selectivity of these peptides was also 
considered. Examination of Figure 2 shows that each of the AC and AM isoforms 
studied was strongly toxic to the normal fibroblast cell line, W138, with toxicity 
levels that were in the range 5-150 μM and comparable to those of their antimicrobial 
activity (Figure 1). These data clearly show that C-terminal amidation of the peptides 
studied does not affect their selectivity for microbial cells over normal eukaryotic 
cells. Strongly supporting this conclusion, it was recently shown that the C-terminal 
amidation of some aureins, which are amphibian defence peptides, had no apparent 
effect on the ability of these peptides to discriminate between prokaryotic and 
eukaryotic cells (REF).   
Based on similarities between the antimicrobial and anticancer actions of 
defence peptides, it has recently been suggested that C-terminal amidification may 
enhance activity of defence peptides against cancer cells (Apponyi et al., 2004). In 
general, the AM and AC isoforms in Table 1 show strong activity against cancer cells 
with levels that are generally in the range, 5-200 μM (Figure 2) and are therefore 
comparable to those of their antimicrobial potency (Figure 1). Analysis of this toxicity 
showed that the AM and AC isoforms of FLAK06, FLAK26, Shiva10(1-18) and 
Modelin-5 were toxic to all cancer cell lines studied but the toxicity of the former 
isoform was up to ten-fold higher than that of the latter (Figure 2). In contrast, whilst 
the AM and AC isoforms of SB-37 and Hectate also showed toxicity to all cancer cell 
lines studied, in these cases, the AC isoform showed levels of toxicity that were up to 
ten-fold higher than that of its AM counterpart (Figure 2). Compared to the other 
peptides studied, the isoforms of CA(1-7)Shiva(1-18), Hectate AC/AM and Shiva10 
showed toxicity to a shorter spectrum of cancer cell lines. However, in all cases, both 
isoforms of these peptides showed anticancer activity with no observed correlation 
between isoform type and the levels of this toxicity (Figure 2). These results clearly 
show that the toxicity of defence peptides to cancer cells can be unaffected, increased 
or decreased by the presence of a C-terminal amide moiety, indicating that this 
structural modification has a variable effect on their anticancer efficacy. Moreover, as 
described above, each of the isoforms studied was strongly toxic to the normal 
fibroblast cell line, W138, indicating that C-terminal amidation does not affect the 
selectivity of these peptides for cancer cells over normal eukaryotic cells in general. 
In summary, in contrast to previously published results on single peptides, this 
analysis shows that C-terminal amidification has a generic effect on either the 
selectivity or the efficacy of defence peptides, which needs to be considered in the 
context of the peptide structure and its target cell. The presence of this structural 
moiety had a variable effect on the toxicity of defence peptides to both microbial and 
cancer cells and it is generally accepted that this toxicity involves membrane invasion 
(Hoskin and Ramamoorthy, 2008). Thus it may be that the additional positive charge 
donated to these peptides by C-terminal amidation leads to changes in some 
physiochemical property such as amphiphilicity that influences their membrane 
interactivity and hence affects their efficacy against target cells. 
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Figure 1. The toxicity of peptides in table 1 to: 1 = Escherichia coli, accession 
number ATCC 25922; 2 = Pseudomonas aeruginosa, accession number ATCC 
27853; 3 = Staphylococcus aureus, accession number ATCC 25923 
 
 
 Figure3. Shown above are the toxicities of individual pairs of C-N and N-N isoforms 
of ACPs (Table 1) when directed against the cell lines: WI38, MCF7, SW480, 
BMKC, H1299, HeLaS3 and PC3. These peptides were: Hectate AC/AM  (A), SB-37 
AC/AM (B), Shiva 10 AC/AM (C), FLAK 06 AC/AM (D), FLAK 26 AC/AM (E), 
Shiva 10(1-18) AC/AM (F), CA(1-7)Shiva10(1-16) AC/AM (G), Modelin-5 
COOH/NH2 (H) and Hectate ACV/AVM (I). For each peptide pair, the toxicity of the 
AC isoform is represented by grey bars and the AM isoform by white bars. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract: The effect of C-terminal amidation on the antimicrobial and hemolytic activities of 
antimicrobial peptides was studied using three cationic peptides which form amphiphilic a-helices when 
bound to membranes. The natural antimicrobial peptide PGLa, the designer-made antibiotic MSI-103, 
and the cell-penetrating "model amphipathic peptide" (MAP) are all amidated in their original forms, and 
their biological activities were compared with the same sequences carrying a free C-terminus. It was 
found that, in general, a free COOH-terminus reduces both the antimicrobial activity and the hemolytic 
side effects of the peptides. The only exception was observed for MSI-103, whose antimicrobial activity 
was not decreased in the acid form. Having shown that the therapeutic index (TI) of this novel peptide is 
significantly higher than for the other tested peptides, with high antibiotic activity and little undesired 
effects, we suggest that it could be a useful starting point for further development of new peptide 
antibiotics. 
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A novel peptide, decoralin, was isolated from the venom of the solitary 
eumenine wasp Oreumenes decoratus. Its sequence, Ser-Leu-Leu-Ser-Leu-
Ile-Arg-Lys-Leu-Ile-Thr, was determined by Edman degradation and 
corroborated by solid-phase synthesis. This sequence has the characteristic 
features of linear cationic α-helical peptides; rich in hydrophobic and basic 
amino acids with no disulfide bond, and accordingly, it can be predicted to 
adopt an amphipathic α-helix secondary structure. In fact, the CD spectra of 
decoralin in the presence of TFE or SDS showed a high α-helical 
conformation content. In a biological evaluation, decoralin exhibited a 
significant broad-spectrum antimicrobial activity, and moderate mast cell 
degranulation and leishmanicidal activities, but showed virtually no hemolytic 
activity. A synthetic analog with C-terminal amidation showed a much more 
potent activity in all the biological assays. 
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Abstract: Analogues of latarcins Ltc1 and Ltc3b, antimicrobial peptides from the venom of the Central 
Asian spider Lachesana tarabaevi capable of formation of amphiphilic structures in membranes without 
involvement of disulfide bonds, were synthesized. The amino acid sequences of the analogues 
correspond to immature forms of these peptides, each of them containing an additional C-terminal 
amino acid residue. It is concluded from the study of the biological activity of the synthesized peptides 
that the posttranslational C-terminal amidation of Ltc3b is a functionally important modification that 
ensures a high activity of the mature peptide. The lipid composition was shown to affect the interaction 
of synthesized peptides with artificial membranes. The analogue of Ltc3b manifested the highest activity 
on cholesterol-containing membranes. The mechanism of action of the studied antimicrobial peptides on 
membranes is discussed. 
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Amidation increases the antimicrobial and……Tritrpticin, a member of the cathelicidin 
family, is a Trp-rich or Pro/Arg-rich peptide. Because the major requirement for an 
antibiotic is for it to be selective for microbes versus human cells, the efficacy of an antimicrobial 
peptide must be determined by comparing the antimicrobial and hemolytic activities (HA) for a given 
peptide (Table 2). This can best be visualized by calculating the therapeutic index for a peptide (Table 
3), the ratio of its hemolytic activity to either its MIC or MBC (HA/MIC or HA/MBC). The selective 
nature of antimicrobial peptides has long been attributed to the differences in the membrane 
compositions of the outer leaflets of mammalian cells (these commonly have neutral zwitterionic 
phospholipids headgroups) and microbial cells (that normally have a net negative charge on their 
surface) (40 ). Therefore, it would be expected that increasing the net positive charge of a peptide by 
amidating the C-terminus should not only increase the antimicrobial activity by removing the repulsion 
with the phosphodiester groups, but also improve the selectivity of the peptide for microbial cells. As 
mentioned above, the increase in the net positive charge by amidating the C-terminus slightly increases 
the antimicrobial activity of tritrpticin, but there is also a corresponding increase in the hemolytic 
activity (Table 2). This suggests that the presence or absence of the negative charge may not improve 
the antimicrobial selectivity of tritrpticin. 
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Abstract 
Human neutrophil α-defensin 2 (HNP2) was N-terminally acetylated and/or C-
terminally amidated, resulting in three terminally modified analogs, Ac-HNP2, 
HNP2-NH2 and Ac-HNP2-NH2. We examined their bactericidal activity against 
E. coli and S. aureus and their ability to induce leakage from large unilamellar 
vesicles. Loss of the N-terminal positive charge was functionally deleterious, 
whereas removal of the C-terminal negative charge enhanced microbial killing 
and membrane permeabilization. Our findings validate the importance of 
electrostatic forces in defensin–microbe interactions and point to the bacterial 
cytoplasmic membrane as a target of HNP2 activity. 
Keywords: Defensin; HNP 
Second, amidation of the C-terminus of HNP2 enhanced bactericidal activity. 
Alos enhanced ability to interact with memebranes  
 
 
There are several characteristics common to these peptides. First, they are all 
cationic, possessing at least two basic residues occurring at positions 7 and 8 
and a free amine at the N-terminal end. Citropin 1.1 is a typical example, with 
sequence GLFDVIKKVASVIGGL-NH2. With the exception of uperin 3.6 (which 
has an Arg at position 7) all the other peptides have the pattern of Lys7 Lys8. 
When one of these basic residues is replaced with Ala, the activity of the 
peptide is reduced remarkably (see citropin synthetic modification 2) but 
replacement of Asp4 with Ala (citropin synthetic modification 1) does not have 
any major influence on the activity. Replacement of both basic residues with 
Ala at positions 7 and 8 results in a lack of observable activity [31]. All the 
peptides are post-translationally modified to the C-terminal amide and this is 
vital for their observed activity. The size of the peptides also influences their 
activities. Sixteen or seventeen residues is the optimal length for these linear 
peptides (cf. aurein 2.1, citropin 1.1 and 1.2, and uperin 3.5 and 3.6). As the 
length decreases (cf. aurein 1.1, 1.2 and dahlein 1.2) or increases (cf. 
maculatin 2.1) the activity decreases. 
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